{"nct_id":"NCT01507831","title":"Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)","status":"COMPLETED","status_verified_date":"2015-11","start_date":"2012-01","start_date_type":null,"primary_completion_date":"2014-11","primary_completion_date_type":"ACTUAL","completion_date":"2014-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}